New treatment strategies and emerging drugs in endometriosis

Bibliography

• Bulun SE. Endometriosis. N Engl J Med 2009;360(3):268-79
   PubMed Web of Science ®Google Scholar
• de Ziegler D, Borghese B, Chapron C. Endometriosis and infertility: pathophysiology and management. Lancet 2010;376(9742):730-8
   PubMed Web of Science ®Google Scholar
• Fauconnier A, Chapron C. Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications. Hum Reprod Update 2005;11(6):595-606
   PubMed Web of Science ®Google Scholar
• Sampson JA. Metastatic or embolic endometriosis, due to the menstrual dissemination of endometrial tissue into the venous circulation. Am J Pathol 1927;3(2):93-110; 43
   PubMedGoogle Scholar
• Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstet Gynecol Clin North Am 1997;24(2):235-58
   PubMed Web of Science ®Google Scholar
• Simoens S, Hummelshoj L, D'Hooghe T. Endometriosis: cost estimates and methodological perspective. Hum Reprod Update 2007;13(4):395-404
   PubMed Web of Science ®Google Scholar
• Chapron C, Pietin-Vialle C, Borghese B, Associated ovarian endometrioma is a marker for greater severity of deeply infiltrating endometriosis. Fertil Steril 2009;92(2):453-7
   PubMed Web of Science ®Google Scholar
• Chapron C, Bourret A, Chopin N, Surgery for bladder endometriosis: long-term results and concomitant management of associated posterior deep lesions. Hum Reprod 2010;25(4):884-9
   PubMed Web of Science ®Google Scholar
• Koninckx PR, Meuleman C, Demeyere S, Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain. Fertil Steril 1991;55(4):759-65
   PubMed Web of Science ®Google Scholar
• Chapron C, Chopin N, Borghese B, Deeply infiltrating endometriosis: pathogenetic implications of the anatomical distribution. Hum Reprod 2006;21(7):1839-45
   PubMed Web of Science ®Google Scholar
• Bricou A, Batt RE, Chapron C. Peritoneal fluid flow influences anatomical distribution of endometriotic lesions: why Sampson seems to be right. Eur J Obstet Gynecol Reprod Biol 2008;138(2):127-34
   PubMed Web of Science ®Google Scholar
• Abrao MS, Podgaec S, Dias JA Jr, Deeply infiltrating endometriosis affecting the rectum and lymph nodes. Fertil Steril 2006;86(3):543-7
   PubMed Web of Science ®Google Scholar
• Noel JC, Chapron C, Fayt I, Lymph node involvement and lymphovascular invasion in deep infiltrating rectosigmoid endometriosis. Fertil Steril 2008;89(5):1069-72
   PubMed Web of Science ®Google Scholar
• Signorile PG, Baldi A. Endometriosis: new concepts in the pathogenesis. Int J Biochem Cell Biol 2010;42(6):778-80
   PubMed Web of Science ®Google Scholar
• Garcia-Velasco JA, Somigliana E. Management of endometriomas in women requiring IVF: to touch or not to touch. Hum Reprod 2009;24(3):496-501
   PubMed Web of Science ®Google Scholar
• Abrao MS, Goncalves MO, Dias JA Jr, Comparison between clinical examination, transvaginal sonography and magnetic resonance imaging for the diagnosis of deep endometriosis. Hum Reprod 2007;22(12):3092-7
   PubMed Web of Science ®Google Scholar
• Piketty M, Chopin N, Dousset B, Preoperative work-up for patients with deeply infiltrating endometriosis: transvaginal ultrasonography must definitely be the first-line imaging examination. Hum Reprod 2009;24(3):602-7
   PubMed Web of Science ®Google Scholar
• Rogers PA, D'Hooghe TM, Fazleabas A, Priorities for endometriosis research: recommendations from an international consensus workshop. Reprod Sci 2009;16(4):335-46
   PubMed Web of Science ®Google Scholar
• Somigliana E, Vercellini P, Vigano P, Non-invasive diagnosis of endometriosis: the goal or own goal? Hum Reprod 2010;25(8):1863-8
   PubMed Web of Science ®Google Scholar
• Mihalyi A, Gevaert O, Kyama CM, Non-invasive diagnosis of endometriosis based on a combined analysis of six plasma biomarkers. Hum Reprod 2010;25(3):654-64
   PubMed Web of Science ®Google Scholar
• Brosens IA. Endometriosis–a disease because it is characterized by bleeding. Am J Obstet Gynecol 1997;176(2):263-7
   PubMed Web of Science ®Google Scholar
• Vercellini P. Endometriosis: what a pain it is. Semin Reprod Endocrinol 1997;15(3):251-61
   PubMedGoogle Scholar
• Anaf V, Simon P, El Nakadi I, Relationship between endometriotic foci and nerves in rectovaginal endometriotic nodules. Hum Reprod 2000;15(8):1744-50
   PubMed Web of Science ®Google Scholar
• Vercellini P, Crosignani PG, Somigliana E, Medical treatment for rectovaginal endometriosis: what is the evidence? Hum Reprod 2009;24(10):2504-14
   PubMed Web of Science ®Google Scholar
• Kennedy S, Bergqvist A, Chapron C, ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod 2005;10(10):2698-704
   Google Scholar
• Petraglia F, Hornung D, Seitz C, Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment. Arch Gynecol Obstet 2012;285(1):167-73
   PubMed Web of Science ®Google Scholar
• Strowitzki T, Marr J, Gerlinger C, Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial. Hum Reprod 2010;25(3):633-41
   PubMed Web of Science ®Google Scholar
• Strowitzki T, Faustmann T, Gerlinger C, Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol 2010;151(2):193-8
   PubMed Web of Science ®Google Scholar
• Vercellini P, Pietropaolo G, De Giorgi O, Reproductive performance in infertile women with rectovaginal endometriosis: is surgery worthwhile? Am J Obstet Gynecol 2006;195(5):1303-10
   PubMed Web of Science ®Google Scholar
• Vercellini P, Crosignani PG, Abbiati A, The effect of surgery for symptomatic endometriosis: the other side of the story. Hum Reprod Update 2009;15(2):177-88
   PubMed Web of Science ®Google Scholar
• Dousset B, Leconte M, Borghese B, Complete surgery for low rectal endometriosis: long-term results of a 100-case prospective study. Ann Surg 2010;251(5):887-95
   PubMed Web of Science ®Google Scholar
• Cheong Y, Tay P, Luk F, Laparoscopic surgery for endometriosis: how often do we need to re-operate? J Obstet Gynaecol 2008;28(1):82-5
   PubMedGoogle Scholar
• Garry R. The effectiveness of laparoscopic excision of endometriosis. Curr Opin Obstet Gynecol 2004;16(4):299-303
   PubMed Web of Science ®Google Scholar
• Somigliana E, Chiodini A, Odorizzi MP, The therapy of endometriosis. New prospects. Minerva Ginecol 2003;55(1):15-23
   PubMedGoogle Scholar
• Weir E, Mustard C, Cohen M, Endometriosis: what is the risk of hospital admission, readmission, and major surgical intervention? J Minim Invasive Gynecol 2005;12(6):486-93
   PubMed Web of Science ®Google Scholar
• Vignali M, Bianchi S, Candiani M, Surgical treatment of deep endometriosis and risk of recurrence. J Minim Invasive Gynecol 2005;12(6):508-13
   PubMed Web of Science ®Google Scholar
• Hachisuga T, Kawarabayashi T. Histopathological analysis of laparoscopically treated ovarian endometriotic cysts with special reference to loss of follicles. Hum Reprod 2002;17(2):432-5
   PubMed Web of Science ®Google Scholar
• Hirokawa W, Iwase A, Goto M, The post-operative decline in serum anti-Mullerian hormone correlates with the bilaterality and severity of endometriosis. Hum Reprod 2011;26(4):904-10
   PubMed Web of Science ®Google Scholar
• Somigliana E, Ragni G, Benedetti F, Does laparoscopic excision of endometriotic ovarian cysts significantly affect ovarian reserve? Insights from IVF cycles. Hum Reprod 2003;18(11):2450-3
   PubMed Web of Science ®Google Scholar
• May KE, Villar J, Kirtley S, Endometrial alterations in endometriosis: a systematic review of putative biomarkers. Hum Reprod Update 2011;17(5):637-53
   PubMed Web of Science ®Google Scholar
• Fedele L, Parazzini F, Radici E, Buserelin acetate versus expectant management in the treatment of infertility associated with minimal or mild endometriosis: a randomized clinical trial. Am J Obstet Gynecol 1992;166(5):1345-50
   PubMed Web of Science ®Google Scholar
• Fedele L, Bianchi S, Arcaini L, Buserelin versus danazol in the treatment of endometriosis-associated infertility. Am J Obstet Gynecol 1989;161(4):871-6
   PubMed Web of Science ®Google Scholar
• Fraser IS, Shearman RP, Jansen RP, A comparative treatment trial of endometriosis using the gonadotrophin-releasing hormone agonist, nafarelin, and the synthetic steroid, danazol. Aust N Z J Obstet Gynaecol 1991;31(2):158-63
   PubMed Web of Science ®Google Scholar
• Henzl MR, Corson SL, Moghissi K, Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial. N Engl J Med 1988;318(8):485-9
   PubMed Web of Science ®Google Scholar
• Rotondi M, Labriola D, Ammaturo FP, Depot leuprorelin acetate versus danazol in the treatment of infertile women with symptomatic endometriosis. Eur J Gynaecol Oncol 2002;23(6):523-6
   PubMed Web of Science ®Google Scholar
• Busacca M, Somigliana E, Bianchi S, Post-operative GnRH analogue treatment after conservative surgery for symptomatic endometriosis stage III-IV: a randomized controlled trial. Hum Reprod 2001;16(11):2399-402
   PubMed Web of Science ®Google Scholar
• Loverro G, Carriero C, Rossi AC, A randomized study comparing triptorelin or expectant management following conservative laparoscopic surgery for symptomatic stage III-IV endometriosis. Eur J Obstet Gynecol Reprod Biol 2008;136(2):194-8
   PubMed Web of Science ®Google Scholar
• Parazzini F, Fedele L, Busacca M, Postsurgical medical treatment of advanced endometriosis: results of a randomized clinical trial. Am J Obstet Gynecol 1994;171(5):1205-7
   PubMed Web of Science ®Google Scholar
• Vercellini P, Crosignani PG, Fadini R, A gonadotrophin-releasing hormone agonist compared with expectant management after conservative surgery for symptomatic endometriosis. Br J Obstet Gynaecol 1999;106(7):672-7
   PubMedGoogle Scholar
• Dicker D, Goldman JA, Levy T, The impact of long-term gonadotropin-releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization-embryo transfer. Fertil Steril 1992;57(3):597-600
   PubMed Web of Science ®Google Scholar
• Rickes D, Nickel I, Kropf S, Increased pregnancy rates after ultralong postoperative therapy with gonadotropin-releasing hormone analogs in patients with endometriosis. Fertil Steril 2002;78(4):757-62
   PubMed Web of Science ®Google Scholar
• Sallam HN, Garcia-Velasco JA, Dias S, Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database Syst Rev 2006(1):CD004635
   Google Scholar
• Surrey ES, Silverberg KM, Surrey MW, Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis. Fertil Steril 2002;78(4):699-704
   PubMed Web of Science ®Google Scholar
• de Ziegler D, Gayet V, Aubriot FX, Use of oral contraceptives in women with endometriosis before assisted reproduction treatment improves outcomes. Fertil Steril 2010;94(7):2796-9
   PubMed Web of Science ®Google Scholar
• Vercellini P, Somigliana E, Vigano P, Surgery for endometriosis-associated infertility: a pragmatic approach. Hum Reprod 2009;24(2):254-69
   PubMed Web of Science ®Google Scholar
• Vercellini P, Fedele L, Aimi G, Reproductive performance, pain recurrence and disease relapse after conservative surgical treatment for endometriosis: the predictive value of the current classification system. Hum Reprod 2006;21(10):2679-85
   PubMed Web of Science ®Google Scholar
• De Ziegler D, Streuli MI, Borghese B, Infertility and endometriosis: a need for global management that optimizes the indications for surgery and ART. Minerva Ginecol 2011;63(4):365-73
   PubMedGoogle Scholar
• Somigliana E, Infantino M, Benedetti F, The presence of ovarian endometriomas is associated with a reduced responsiveness to gonadotropins. Fertil Steril 2006;86(1):192-6
   PubMed Web of Science ®Google Scholar
• Somigliana E, Vercellini P, Vigano P, Should endometriomas be treated before IVF-ICSI cycles? Hum Reprod Update 2006;12(1):57-64
   PubMed Web of Science ®Google Scholar
• Zondervan KT, Yudkin PL, Vessey MP, Prevalence and incidence of chronic pelvic pain in primary care: evidence from a national general practice database. Br J Obstet Gynaecol 1999;106(11):1149-55
   PubMedGoogle Scholar
• Kyama MC, D'Hooghe TM, Debrock S, The prevalence of endometriosis among African-American and African-indigenous women. Gynecol Obstet Invest 2004;57(1):40-2
   PubMed Web of Science ®Google Scholar
• Vigano P, Parazzini F, Somigliana E, Endometriosis: epidemiology and aetiological factors. Best Pract Res Clin Obstet Gynaecol 2004;18(2):177-200
   PubMed Web of Science ®Google Scholar
• Laufer MR, Goitein L, Bush M, Prevalence of endometriosis in adolescent girls with chronic pelvic pain not responding to conventional therapy. J Pediatr Adolesc Gynecol 1997;10(4):199-202
   PubMedGoogle Scholar
• Gao X, Outley J, Botteman M, Economic burden of endometriosis. Fertil Steril 2006;86(6):1561-72
   PubMed Web of Science ®Google Scholar
• Kunz K KM, Moynihan C, Williamson A, Mazonson P. The cost of treatment of endometriosisin the California Medicaid population. Am J Manag Care 1995(1):25-9
   Google Scholar
• Available from: www.globaldata.com
   Google Scholar
• Available from: www.prnewswire.com
   Google Scholar
• Pipeline Insight: Endometriosis- New therapies near market while more innovative targets still needed, executive summary. Available from: www.datamonitor.com; 10.12.2009:Chapter 1
   Google Scholar
• Chapron C, Borghese B, Streuli I, Markers of adult endometriosis detectable in adolescence. J Pediatr Adolesc Gynecol 2011;24(5 Suppl):S7-12
   PubMed Web of Science ®Google Scholar
• Chapron C, Souza C, Borghese B, Oral contraceptives and endometriosis: the past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosis. Hum Reprod 2011;26(8):2028-35
   PubMed Web of Science ®Google Scholar
• Chapron C, Lafay-Pillet MC, Monceau E, Questioning patients about their adolescent history can identify markers associated with deep infiltrating endometriosis. Fertil Steril 2011;95(3):877-81
   PubMed Web of Science ®Google Scholar
• Treloar SA, Bell TA, Nagle CM, Early menstrual characteristics associated with subsequent diagnosis of endometriosis. Am J Obstet Gynecol 2010;202(6):534; e1-6
   PubMedGoogle Scholar
• Martinez-Conejero JA, Morgan M, Montesinos M, Adenomyosis does not affect implantation, but is associated with miscarriage in patients undergoing oocyte donation. Fertil Steril 2011;96(4):943-50
   PubMed Web of Science ®Google Scholar
• Maubon A, Faury A, Kapella M, Uterine junctional zone at magnetic resonance imaging: a predictor of in vitro fertilization implantation failure. J Obstet Gynaecol Res 2010;36(3):611-18
   PubMed Web of Science ®Google Scholar
• Bulun SE, Sharda G, Rink J, Distribution of aromatase P450 transcripts and adipose fibroblasts in the human breast. J Clin Endocrinol Metab 1996;81(3):1273-7
   PubMed Web of Science ®Google Scholar
• Colette S, Lousse JC, Defrere S, Absence of aromatase protein and mRNA expression in endometriosis. Hum Reprod 2009;24(9):2133-41
   PubMed Web of Science ®Google Scholar
• Colette S, Donnez J. Are aromatase inhibitors effective in endometriosis treatment? Expert Opin Investig Drugs 2011;20(7):917-31
   PubMed Web of Science ®Google Scholar
• Lossl K, Loft A, Freiesleben NL, Combined down-regulation by aromatase inhibitor and GnRH-agonist in IVF patients with endometriomas-A pilot study. Eur J Obstet Gynecol Reprod Biol 2009;144(1):48-53
   PubMed Web of Science ®Google Scholar
• Soysal S, Soysal ME, Ozer S, The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial. Hum Reprod 2004;19(1):160-7
   PubMed Web of Science ®Google Scholar
• Alborzi S, Hamedi B, Omidvar A, A comparison of the effect of short-term aromatase inhibitor (letrozole) and GnRH agonist (triptorelin) versus case control on pregnancy rate and symptom and sign recurrence after laparoscopic treatment of endometriosis. Arch Gynecol Obstet 2011;284(1):105-10
   PubMed Web of Science ®Google Scholar
• Available from: www.ClinicalTrials.gov [Accessed on December 2011]
   Google Scholar
• Struthers RS, Nicholls AJ, Grundy J, Suppression of gonadotropins and estradiol in premenopausal women by oral administration of the nonpeptide gonadotropin-releasing hormone antagonist elagolix. J Clin Endocrinol Metab 2009;94(2):545-51
   PubMed Web of Science ®Google Scholar
• Bouchard P, Chabbert-Buffet N, Fauser BC. Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety. Fertil Steril 2011;96(5):1175-89
   PubMed Web of Science ®Google Scholar
• Gopalkrishnan K, Katkam RR, Sachdeva G, Effects of an antiprogestin onapristone on the endometrium of bonnet monkeys: morphometric and ultrastructural studies. Biol Reprod 2003;68(6):1959-67
   PubMed Web of Science ®Google Scholar
• Brenner RM, Slayden OD, Nath A, Intrauterine administration of CDB-2914 (Ulipristal) suppresses the endometrium of rhesus macaques. Contraception 2010;81(4):336-42
   PubMed Web of Science ®Google Scholar
• Grow DR, Williams RF, Hsiu JG, Antiprogestin and/or gonadotropin-releasing hormone agonist for endometriosis treatment and bone maintenance: a 1-year primate study. J Clin Endocrinol Metab 1996;81(5):1933-9
   PubMed Web of Science ®Google Scholar
• Kettel LM, Murphy AA, Morales AJ, Treatment of endometriosis with the antiprogesterone mifepristone (RU486). Fertil Steril 1996;65(1):23-8
   PubMed Web of Science ®Google Scholar
• Kettel LM, Murphy AA, Morales AJ, Preliminary report on the treatment of endometriosis with low-dose mifepristone (RU 486). Am J Obstet Gynecol 1998;178(6):1151-6
   PubMed Web of Science ®Google Scholar
• Clarke BL, Khosla S. New selective estrogen and androgen receptor modulators. Curr Opin Rheumatol 2009;21(4):374-9
   PubMed Web of Science ®Google Scholar
• Buelke-Sam J, Bryant HU, Francis PC. The selective estrogen receptor modulator, raloxifene: an overview of nonclinical pharmacology and reproductive and developmental testing. Reprod Toxicol 1998;12(3):217-21
   PubMed Web of Science ®Google Scholar
• Yao Z, Shen X, Capodanno I, Validation of rat endometriosis model by using raloxifene as a positive control for the evaluation of novel SERM compounds. J Invest Surg 2005;18(4):177-83
   PubMed Web of Science ®Google Scholar
• Stratton P, Sinaii N, Segars J, Return of chronic pelvic pain from endometriosis after raloxifene treatment: a randomized controlled trial. Obstet Gynecol 2008;111(1):88-96
   PubMed Web of Science ®Google Scholar
• Guo SW, Olive DL. Two unsuccessful clinical trials on endometriosis and a few lessons learned. Gynecol Obstet Invest 2007;64(1):24-35
   PubMed Web of Science ®Google Scholar
• Brandenberger AW, Lebovic DI, Tee MK, Oestrogen receptor (ER)-alpha and ER-beta isoforms in normal endometrial and endometriosis-derived stromal cells. Mol Hum Reprod 1999;5(7):651-5
   PubMed Web of Science ®Google Scholar
• Cavallini A, Resta L, Caringella AM, Involvement of estrogen receptor-related receptors in human ovarian endometriosis. Fertil Steril 2011;96(1):102-6
   PubMed Web of Science ®Google Scholar
• Bukulmez O, Hardy DB, Carr BR, Inflammatory status influences aromatase and steroid receptor expression in endometriosis. Endocrinology 2008;149(3):1190-204
   PubMed Web of Science ®Google Scholar
• Harris HA, Bruner-Tran KL, Zhang X, A selective estrogen receptor-beta agonist causes lesion regression in an experimentally induced model of endometriosis. Hum Reprod 2005;20(4):936-41
   PubMed Web of Science ®Google Scholar
• Nap AW, Griffioen AW, Dunselman GA, Antiangiogenesis therapy for endometriosis. J Clin Endocrinol Metab 2004;89(3):1089-95
   PubMed Web of Science ®Google Scholar
• Nisolle M, Casanas-Roux F, Anaf V, Morphometric study of the stromal vascularization in peritoneal endometriosis. Fertil Steril 1993;59(3):681-4
   PubMed Web of Science ®Google Scholar
• McLaren J, Prentice A, Charnock-Jones DS, Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Hum Reprod 1996;11(1):220-3
   PubMed Web of Science ®Google Scholar
• McLaren J, Prentice A, Charnock-Jones DS, Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J Clin Invest 1996;98(2):482-9
   PubMed Web of Science ®Google Scholar
• Taylor RN, Yu J, Torres PB, Mechanistic and therapeutic implications of angiogenesis in endometriosis. Reprod Sci 2009;16(2):140-6
   PubMed Web of Science ®Google Scholar
• Machado DE, Abrao MS, Berardo PT, Vascular density and distribution of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) are significantly higher in patients with deeply infiltrating endometriosis affecting the rectum. Fertil Steril 2008;90(1):148-55
   PubMed Web of Science ®Google Scholar
• Ricci AG, Olivares CN, Bilotas MA, Effect of vascular endothelial growth factor inhibition on endometrial implant development in a murine model of endometriosis. Reprod Sci 2011;18(7):614-22
   PubMed Web of Science ®Google Scholar
• Novella-Maestre E, Carda C, Noguera I, Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis. Hum Reprod 2009;24(5):1025-35
   PubMed Web of Science ®Google Scholar
• Delgado-Rosas F, Gomez R, Ferrero H, The effects of ergot and non-ergot-derived dopamine agonists in an experimental mouse model of endometriosis. Reproduction 2011;142(5):745-55
   PubMed Web of Science ®Google Scholar
• Barlier A, Jaquet P. Quinagolide–a valuable treatment option for hyperprolactinaemia. Eur J Endocrinol 2006;154(2):187-95
   PubMed Web of Science ®Google Scholar
• dos Santos Nunes V, El Dib R, Boguszewski CL, Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: a systematic review of randomized controlled trials and meta-analysis. Pituitary 2011;14(3):259-65
   PubMed Web of Science ®Google Scholar
• Stalldecker G, Mallea-Gil MS, Guitelman M, Effects of cabergoline on pregnancy and embryo-fetal development: retrospective study on 103 pregnancies and a review of the literature. Pituitary 2010;13(4):345-50
   PubMed Web of Science ®Google Scholar
• Valassi E, Klibanski A, Biller BM. Clinical Review#: potential cardiac valve effects of dopamine agonists in hyperprolactinemia. J Clin Endocrinol Metab 2010;95(3):1025-33
   PubMed Web of Science ®Google Scholar
• Zanettini R, Antonini A, Gatto G, Valvular heart disease and the use of dopamine agonists for Parkinson's disease. N Engl J Med 2007;356(1):39-46
   PubMed Web of Science ®Google Scholar
• Gomez R, Abad A, Delgado F, Effects of hyperprolactinemia treatment with the dopamine agonist quinagolide on endometriotic lesions in patients with endometriosis-associated hyperprolactinemia. Fertil Steril 2011;95(3):882-8; e1
   PubMed Web of Science ®Google Scholar
• Bruner-Tran KL, Osteen KG, Duleba AJ. Simvastatin protects against the development of endometriosis in a nude mouse model. J Clin Endocrinol Metab 2009;94(7):2489-94
   PubMed Web of Science ®Google Scholar
• Esfandiari N, Khazaei M, Ai J, Effect of a statin on an in vitro model of endometriosis. Fertil Steril 2007;87(2):257-62
   PubMed Web of Science ®Google Scholar
• Yilmaz B, Ozat M, Kilic S, Atorvastatin causes regression of endometriotic implants in a rat model. Reprod Biomed Online 2010;20(2):291-9
   PubMed Web of Science ®Google Scholar
• Bedaiwy MA, Falcone T, Sharma RK, Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. Hum Reprod 2002;17(2):426-31
   PubMed Web of Science ®Google Scholar
• Richter ON, Dorn C, Rosing B, Tumor necrosis factor alpha secretion by peritoneal macrophages in patients with endometriosis. Arch Gynecol Obstet 2005;271(2):143-7
   PubMedGoogle Scholar
• Hill JA, Haimovici F, Anderson DJ. Products of activated lymphocytes and macrophages inhibit mouse embryo development in vitro. J Immunol 1987;139(7):2250-4
   PubMed Web of Science ®Google Scholar
• Falconer H, Mwenda JM, Chai DC, Treatment with anti-TNF monoclonal antibody (c5N) reduces the extent of induced endometriosis in the baboon. Hum Reprod 2006;21(7):1856-62
   PubMed Web of Science ®Google Scholar
• D'Hooghe TM, Nugent NP, Cuneo S, Recombinant human TNFRSF1A (r-hTBP1) inhibits the development of endometriosis in baboons: a prospective, randomized, placebo- and drug-controlled study. Biol Reprod 2006;74(1):131-6
   PubMed Web of Science ®Google Scholar
• Koninckx PR, Craessaerts M, Timmerman D, Anti-TNF-alpha treatment for deep endometriosis-associated pain: a randomized placebo-controlled trial. Hum Reprod 2008;23(9):2017-23
   PubMed Web of Science ®Google Scholar
• Guo SW. Emerging drugs for endometriosis. Expert Opin Emerg Drugs 2008;13(4):547-71
   PubMed Web of Science ®Google Scholar
• Lv D, Song H, Li Y, Pentoxifylline versus medical therapies for subfertile women with endometriosis. Cochrane Database Syst Rev 2009(3):CD007677
   Google Scholar
• Marques LJ, Zheng L, Poulakis N, Pentoxifylline inhibits TNF-alpha production from human alveolar macrophages. Am J Respir Crit Care Med 1999;159(2):508-11
   PubMed Web of Science ®Google Scholar
• Nothnick WB, Curry TE, Vernon MW. Immunomodulation of rat endometriotic implant growth and protein production. Am J Reprod Immunol 1994;31(2-3):151-62
   PubMed Web of Science ®Google Scholar
• Steinleitner A, Lambert H, Suarez M, Immunomodulation in the treatment of endometriosis-associated subfertility: use of pentoxifylline to reverse the inhibition of fertilization by surgically induced endometriosis in a rodent model. Fertil Steril 1991;56(5):975-9
   PubMed Web of Science ®Google Scholar
• Steinleitner A, Lambert H, Roy S. Immunomodulation with pentoxifylline abrogates macrophage-mediated infertility in an in vivo model: a paradigm for a novel approach to the treatment of endometriosis-associated subfertility. Fertil Steril 1991;55(1):26-31
   PubMed Web of Science ®Google Scholar
• Alborzi S, Ghotbi S, Parsanezhad ME, Pentoxifylline therapy after laparoscopic surgery for different stages of endometriosis: a prospective, double-blind, randomized, placebo-controlled study. J Minim Invasive Gynecol 2007;14(1):54-8
   PubMed Web of Science ®Google Scholar
• Balasch J, Creus M, Fabregues F, Pentoxifylline versus placebo in the treatment of infertility associated with minimal or mild endometriosis: a pilot randomized clinical trial. Hum Reprod 1997;12(9):2046-50
   PubMed Web of Science ®Google Scholar
• Creus M, Fabregues F, Carmona F, Combined laparoscopic surgery and pentoxifylline therapy for treatment of endometriosis-associated infertility: a preliminary trial. Hum Reprod 2008;23(8):1910-16
   PubMed Web of Science ®Google Scholar
• Kamencic H, Thiel JA. Pentoxifylline after conservative surgery for endometriosis: a randomized, controlled trial. J Minim Invasive Gynecol 2008;15(1):62-6
   PubMed Web of Science ®Google Scholar
• Olivares C, Ricci A, Bilotas M, The inhibitory effect of celecoxib and rosiglitazone on experimental endometriosis. Fertil Steril 2011;96(2):428-33
   PubMed Web of Science ®Google Scholar
• Sharma I, Dhawan V, Saha SC, In vitro effects of peroxisome proliferator-activated receptor-gamma ligands on gene expression in lipopolysaccharide-induced endometrial and endometriotic stromal cells. Fertil Steril 2011;95(2):829-31; e1-5
   PubMed Web of Science ®Google Scholar
• Nissen SE. Perspective: effect of rosiglitazone on cardiovascular outcomes. Curr Cardiol Rep 2007;9(5):343-4
   PubMedGoogle Scholar
• Peeters LL, Vigne JL, Tee MK, PPAR gamma represses VEGF expression in human endometrial cells: implications for uterine angiogenesis. Angiogenesis 2005;8(4):373-9
   PubMedGoogle Scholar
• Lebovic DI, Mwenda JM, Chai DC, PPAR-gamma receptor ligand induces regression of endometrial explants in baboons: a prospective, randomized, placebo- and drug-controlled study. Fertil Steril 2007;88(4 Suppl):1108-19
   PubMedGoogle Scholar
• Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 2007;356(24):2457-71
   PubMed Web of Science ®Google Scholar
• Borghese B, Vaiman D, Mondon F, Neurotrophins and pain in endometriosis. Gynecol Obstet Fertil 2010;38(7-8):442-6
   PubMed Web of Science ®Google Scholar
• Bulun SE, Cheng YH, Pavone ME, Estrogen receptor-beta, estrogen receptor-alpha, and progesterone resistance in endometriosis. Semin Reprod Med 2010;28(1):36-43
   PubMed Web of Science ®Google Scholar
• Boonyaratanakornkit V. Scaffolding proteins mediating membrane-initiated extra-nuclear actions of estrogen receptor. Steroids 2011;76(9):877-84
   PubMed Web of Science ®Google Scholar
• Lu Q, Pallas DC, Surks HK, Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor alpha. Proc Natl Acad Sci USA 2004;101(49):17126-31
   PubMed Web of Science ®Google Scholar
• Leconte M, Nicco C, Ngo C, Antiproliferative effects of cannabinoid agonists on deep infiltrating endometriosis. Am J Pathol 2010;177(6):2963-70
   PubMed Web of Science ®Google Scholar
• Leconte M, Nicco C, Ngo C, The mTOR/AKT inhibitor temsirolimus prevents deep infiltrating endometriosis in mice. Am J Pathol 2011;179(2):880-9
   PubMed Web of Science ®Google Scholar
• Ngo C, Chereau C, Nicco C, Reactive oxygen species controls endometriosis progression. Am J Pathol 2009;175(1):225-34
   PubMed Web of Science ®Google Scholar
• Halme J, Becker S, Haskill S. Altered maturation and function of peritoneal macrophages: possible role in pathogenesis of endometriosis. Am J Obstet Gynecol 1987;156(4):783-9
   PubMed Web of Science ®Google Scholar
• Halme J, White C, Kauma S, Peritoneal macrophages from patients with endometriosis release growth factor activity in vitro. J Clin Endocrinol Metab 1988;66(5):1044-9
   PubMed Web of Science ®Google Scholar
• Ngo C, Nicco C, Leconte M, Protein kinase inhibitors can control the progression of endometriosis in vitro and in vivo. J Pathol 2010;222(2):148-57
   PubMed Web of Science ®Google Scholar
• Tang L, Wang TT, Wu YT, High expression levels of cyclin B1 and Polo-like kinase 1 in ectopic endometrial cells associated with abnormal cell cycle regulation of endometriosis. Fertil Steril 2009;91(4):979-87
   PubMed Web of Science ®Google Scholar
• Ngo C, Nicco C, Leconte M, Antiproliferative effects of anastrozole, methotrexate, and 5-fluorouracil on endometriosis in vitro and in vivo. Fertil Steril 2010;94(5):1632-8; e1
   PubMed Web of Science ®Google Scholar
• Wang Y, Sharma RK, Falcone T, Importance of reactive oxygen species in the peritoneal fluid of women with endometriosis or idiopathic infertility. Fertil Steril 1997;68(5):826-30
   PubMed Web of Science ®Google Scholar
• Batteux F, Kavian N, Servettaz A. New insights on chemically induced animal models of systemic sclerosis. Curr Opin Rheumatol 2011;23(6):511-18
   PubMed Web of Science ®Google Scholar
• Dooley A, Bruckdorfer KR, Abraham DJ. Modulation of fibrosis in systemic sclerosis by nitric oxide and antioxidants. Cardiol Res Pract 2012;2012:521958
   PubMedGoogle Scholar
• Anaf V, Simon P, Fayt I, Smooth muscles are frequent components of endometriotic lesions. Hum Reprod 2000;15(4):767-71
   PubMed Web of Science ®Google Scholar
• Yoshino O, Osuga Y, Hirota Y, Possible pathophysiological roles of mitogen-activated protein kinases (MAPKs) in endometriosis. Am J Reprod Immunol 2004;52(5):306-11
   PubMed Web of Science ®Google Scholar
• Yotova IY, Quan P, Leditznig N, Abnormal activation of Ras/Raf/MAPK and RhoA/ROCKII signalling pathways in eutopic endometrial stromal cells of patients with endometriosis. Hum Reprod 2011;26(4):885-97
   PubMed Web of Science ®Google Scholar
• Chang RJ, Laufer LR, Meldrum DR, Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist. J Clin Endocrinol Metab 1983;56(5):897-903
   PubMed Web of Science ®Google Scholar
• Meldrum DR, Chang RJ. Lu J, et al. "Medical oophorectomy" using a long-acting GNRH agonist–a possible new approach to the treatment of endometriosis. J Clin Endocrinol Metab 1982;54(5):1081-3
   PubMed Web of Science ®Google Scholar
• Steingold KA, Cedars M, Lu JK, Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist. Obstet Gynecol 1987;69(3 Pt 1):403-11
   PubMed Web of Science ®Google Scholar
• Schriock E, Monroe SE, Henzl M, Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin). Fertil Steril 1985;44(5):583-8
   PubMed Web of Science ®Google Scholar
• Hickok LR, Burry KA, Cohen NL, Medical treatment of endometriosis: a comparison of the suppressive effects of danazol and nafarelin on reproductive hormones. Fertil Steril 1991;56(4):622-7
   PubMed Web of Science ®Google Scholar
• Kennedy SH, Williams IA, Brodribb J, A comparison of nafarelin acetate and danazol in the treatment of endometriosis. Fertil Steril 1990;53(6):998-1003
   PubMed Web of Science ®Google Scholar
• Tummon IS, Pepping ME, Binor Z, A randomized, prospective comparison of endocrine changes induced with intranasal leuprolide or danazol for treatment of endometriosis. Fertil Steril 1989;51(3):390-4
   PubMed Web of Science ®Google Scholar
• Tummon IS, Ali A, Pepping ME, Bone mineral density in women with endometriosis before and during ovarian suppression with gonadotropin-releasing hormone agonists or danazol. Fertil Steril 1988;49(5):792-6
   PubMed Web of Science ®Google Scholar
• Friedman AJ, Hornstein MD. Gonadotropin-releasing hormone agonist plus estrogen-progestin "add-back" therapy for endometriosis-related pelvic pain. Fertil Steril 1993;60(2):236-41
   PubMed Web of Science ®Google Scholar
• Hornstein MD, Surrey ES, Weisberg GW, Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. Lupron Add-Back Study Group. Obstet Gynecol 1998;91(1):16-24
   PubMed Web of Science ®Google Scholar
• Surrey ES, Hornstein MD. Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up. Obstet Gynecol 2002;99(5 Pt 1):709-19
   PubMed Web of Science ®Google Scholar
• Seracchioli R, Mabrouk M, Frasca C, Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial. Fertil Steril 2010;93(1):52-6
   PubMed Web of Science ®Google Scholar
• Vercellini P, Somigliana E, Daguati R, Postoperative oral contraceptive exposure and risk of endometrioma recurrence. Am J Obstet Gynecol 2008;198(5):504; e1-5
   PubMed Web of Science ®Google Scholar
• Mizutani T, Nishiyama S, Amakawa I, Danazol concentrations in ovary, uterus, and serum and their effect on the hypothalamic-pituitary-ovarian axis during vaginal administration of a danazol suppository. Fertil Steril 1995;63(6):1184-9
   PubMed Web of Science ®Google Scholar
• Kim YA, Kim MR, Lee JH, Gonadotropin-releasing hormone agonist reduces aromatase cytochrome P450 and cyclooxygenase-2 in ovarian endometrioma and eutopic endometrium of patients with endometriosis. Gynecol Obstet Invest 2009;68(2):73-81
   PubMed Web of Science ®Google Scholar
• Tokushige N, Markham R, Russell P, Effect of progestogens and combined oral contraceptives on nerve fibers in peritoneal endometriosis. Fertil Steril 2009;92(4):1234-9
   PubMed Web of Science ®Google Scholar
• Abushahin F, Goldman KN, Barbieri E, Aromatase inhibition for refractory endometriosis-related chronic pelvic pain. Fertil Steril 2011;96(4):939-42
   PubMed Web of Science ®Google Scholar